Sophia Amoruso of "Girlboss" fame, who built Nasty Gal from scratch to a peak valuation of $350 million, warned founders ...

This is an edition of the WSJ Careers & Leadership newsletter, a weekly digest to help you get ahead and stay informed about careers, business, management and leadership. If you’re not subscribed, ...

OpenAI just introduced a new shopping feature that allows people to buy items directly from online retailers from inside ChatGPT — a move that instantly attracted online jeers from critics who framed ...

Adobe stock (NASDAQ: ADBE) is down 22% this year, primarily due to rising concerns centered on rising competition from both lower-cost creative software alternatives and new AI-powered tools, combined ...

Households should keep some cash at home so they can pay for essentials during crises, according to an analysis of four major disruptive events in Europe, including the pandemic and Russia’s invasion ...

Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. If you're looking for a $0 annual fee cash back card, the Blue Cash Everyday® Card from American Express ...

Every year, analysts at TD Cowen survey companies to learn more about their spending plans for cloud computing. This year, 215 companies of various sizes participated in the survey. The responses ...

Americans are sitting on more than $39 billion of matured but unredeemed U.S. savings bonds, according to the Treasury Department, but cashing them isn’t as simple as it was. Electronic savings bonds ...

Kwik Trip is stopping the use of pennies in cash transactions due to the U.S. Treasury's decision to end penny production. It's implementing a "penny-free" cash-rounding policy where the purchases ...

Welcome to Tech In Depth, our daily newsletter about the business of tech from Bloomberg’s journalists around the world. Today, Brody Ford looks at one of the downsides of Oracle’s leap into ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Sabrina Karl has over two decades of experience writing about savings, CDs, and ...

Bolt Biotherapeutics has halved its workforce for the second time in two years as the oncology biotech delays a readout of its lead immunotherapy. The company had previously been expecting initial ...